Edition:
United Kingdom

Spring Bank Pharmaceuticals Inc (SBPH.OQ)

SBPH.OQ on NASDAQ Stock Exchange Capital Market

9.59USD
22 Mar 2019
Change (% chg)

-- (--)
Prev Close
$9.59
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,522
52-wk High
$15.52
52-wk Low
$8.14

Chart for

About

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics using its small molecule nucleic acid hybrid (SMNH) chemistry platform. The Company is developing its SMNH product, SB 9200, for the treatment of viral diseases. The... (more)

Overall

Beta: --
Market Cap(Mil.): $208.23
Shares Outstanding(Mil.): 12.70
Dividend: --
Yield (%): --

Financials

  SBPH.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -2.44 -- --
ROI: -61.33 8.89 13.82
ROE: -73.77 10.02 15.24

Earnings vs. Estimates